Top Tweets for #Astro22
Congratulations on updating the cohort previously presented at #ASTRO22 and getting this crucial study finally published. A recent literature search suggests this may be only the second peer-reviewed publication reporting the in-field LC rate with the PACIFIC regimen (EA5181 is not yet published). The other report is by Shaverdian et al., 2021: https://t.co/Ncyolxxr3u
A group in the VA is planning to examine the same comparison endpoint using a 2,000-patient dataset to further explore how PD-L1 inhibitors interact with CRT. The measured LC rate in each of these studies is critical to understanding the value of intensifying local therapy with additional RT or surgery, given each of those strategies also increase the risk of severe complications.

One of my favourite talks from #ASTRO22 and now the paper has dropped in @IJROBP from @imrtlee @MSK_RadOnc H&N #hncsm #RadOnc team.
AI-enabled offline CT-adaptive XRT on conventional LINAC.
W/ better CBCT (eg HyperSight) potential benefit may even ⬆️
https://t.co/rWqouAE4oD

VERY cool study by Dr. Aliotta (@MSK_RadOnc PI: @imrtlee) at @ASTRO_org #astro22 on offline ART for oropharynx ca using daily CBCT triggered by GTV delta of 20%+ OR at 3 weeks if <20%. Significant improvement in PTV coverage and OAR sparing. #hncsm #radonc
1/2

🎯 NEWS: Advances in #Radiotherapy mean it’s now possible to treat low to medium-risk, localised #ProstateCancer in just five sessions. Results from the PACE-B trial led by @royalmarsdenNHS and the ICR will be presented at #ASTRO22 on Monday.
Read more 👇
https://t.co/kRRiI4i1HZ
Paper for the AMAZING study by @ErinGillespieMD (now @uwradonc) and @MSK_RadOnc now in @JCO_ASCO!
https://t.co/giJebZugVo
Huge highlight of #ASTRO22

The most recent TAP episode with @j_luh reminded me of another we recorded with @bananaP08.
Way back in the aftermath of #ASTRO22.
This was a great ep!
Trivia: this is the first and only episode where we (sort of) recorded in person.
https://t.co/gpEwSQu4aC
From shooting hoops to shooting stars - AstroNiGht22 had it all!🚀 One year on, the memories still score big!
#Astro22🚀 #Astroeverywhere!!

Still think about this talk by @KaramLab at #ASTRO22 @ASTRO_org. One of those true 🤯💡moments.
Associated papers:
https://t.co/1x0VpIcy6X
https://t.co/HG0TMNiAjk
Results of the collab were presented at #ASTRO22: https://t.co/grCGeZr5Ey
Dr. Ohri is leading a related NRG trial
Dr. Hong received an R01 to test the model at multiple clinics
🚨@OncoAlert EXTEND published!
Presented by @ChadTangMD at #ASTRO22, great to see this in print @JAMAOnc
✅Addition of MDT to intermittent hormone therapy in oligometastatic #prostatecancer improved PFS, ⏲️to new lesion failure, eugonadal PFS
#pcsm
https://t.co/rONrtKXTYK

Member Benefit: ASTRO members get FREE access to one of the Science Highlights sessions presented at the #ASTRO22. These sessions highlight key findings in a particular track while featuring cutting-edge research from leaders in the field. Learn more: https://t.co/yMl1dSVVl7

Did you run (or walk!) the #ROI5k 2022? Share your experience and be eligible to win a FREE regi for this year's race at @ASTRO_org! https://t.co/dazdUExc3f

Open access: #ASTRO22 Presidential Symposium session IV, "EI and AI: Caring for the Patient in a Wireless World." View the session, Human Doctors, Human Patients, here: https://t.co/PypLgxF7VV

@DrJohnKang @SimonLo21054188 @UCLA @uwradonc @PeterMacRadOnc @RadoncUsc @BeaumontRadOnc @QueensRadOnc @UTDROResidents @IUradonc @StanfordRO_Res @PennRadOnc @EmoryRadOncRes @DouglasEWood1 @JeffBradleyMD @MSK_RadOnc The Canadians also reported data on this topic at #ASTRO22, noting “Osi hold”patterns were variable. 🔥 topic! @DrAlexLouie @cancermd https://t.co/Bfznr1m6Sp
For this final post of #BlackHistoryMonth, a nice throwback to a gathering at #ASTRO22 with members of the association of black radiation oncologists (#ABRO). Learn about other Black leaders in #radonc:
https://t.co/xHJf5Tk3wf

@SprakerMDPhD @ParikhSimul @jaguaranna27 @ACRORadOnc @ACROresident @SbrtSean @PCFnews @DrSpratticus @_ShankarSiva @TylerSbrt @DrLesterColl @Icro_Meattini @AmarUKishan @ARRO_org @ProstateUK @subatomicdoc @pre_rad @jryckman3 @A_CT_SimMDJD @sophia_kamran @j_luh @sbrtmemes @NicholasZaorsky Reminiscent of this conversation from #ASTRO22

What a thrill to meet a person I so admire at #ASTRO22. I didn't get a📸w/him as the line of admirers was too long but here's a nice one w/Dr. Thomas. A most deserving @ASTRO_org Honorary Member & a true leader in #cancer care. @DrRobWinn

#BlackHistoryMonth is a time to honor the past, celebrate the present & look to the future. This month we spotlight #cancer leaders, such as Dr. Robert Winn. https://t.co/kgQQcgOCE2 @DrRobWinn @VCUMassey

@GitaSuneja @ValenciaHenry_ @ASTRO_org @theNCI Not surprised at all! And here she is presenting at #ASTRO22. Def a super⭐️ and one of my fav people!!

Last Seen Hashtags on Sotwe
SundayThroatHugs
Seen from United Kingdom
CNo101S・H・DarkKnight
Seen from United States
cumclean
omegle()**** filter:native_video
Seen from Poland
bacolartis
Seen from Indonesia
FoodandBeverage
Seen from Ecuador
Zipolite
Seen from Mexico
nolimit #momson #teenagergirls teenagee
Seen from Chile
yoheidoaWPPHVLC
Seen from Peru
groommetwt
Seen from United States
Most Popular Users

Elon Musk 
@elonmusk
240.6M followers

Barack Obama 
@barackobama
119.2M followers

Donald J. Trump 
@realdonaldtrump
111.7M followers

Cristiano Ronaldo 
@cristiano
110.5M followers

Narendra Modi 
@narendramodi
107M followers

Rihanna 
@rihanna
97.6M followers

NASA 
@nasa
92.2M followers

Justin Bieber 
@justinbieber
90.9M followers

KATY PERRY 
@katyperry
87.6M followers

Taylor Swift 
@taylorswift13
81.4M followers

Lady Gaga 
@ladygaga
73M followers

Virat Kohli 
@imvkohli
69.8M followers

Kim Kardashian 
@kimkardashian
69.8M followers

YouTube 
@youtube
68.7M followers

Bill Gates 
@billgates
63.9M followers

Neymar Jr 
@neymarjr
62.5M followers

The Ellen Show
@theellenshow
62.4M followers

CNN 
@cnn
61.9M followers

X 
@x
60.8M followers

Selena Gomez 
@selenagomez
60.7M followers


























